SUPRATENTORIAL GLIOBLASTOMA
Clinical trials for SUPRATENTORIAL GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new SUPRATENTORIAL GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for SUPRATENTORIAL GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental virus therapy for brain cancer trial pulled before it began
Disease control TerminatedThis study planned to test a two-part experimental treatment for newly diagnosed glioblastoma, a fast-growing brain cancer. The treatment combined a modified virus (Toca 511) designed to enter tumor cells and an extended-release antifungal drug (Toca FC) that the virus helps turn…
Matched conditions: SUPRATENTORIAL GLIOBLASTOMA
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Immunotherapy combo shows promise in tough brain cancer trial
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation can help people with newly diagnosed glioblastoma, a fast-growing brain cancer. About 52 adults with this diagnosis will receive the combination therapy. The main goals are…
Matched conditions: SUPRATENTORIAL GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC